AnaptysBio

AnaptysBio

AnaptysBio

AnaptysBio is a biotechnology company developing novel therapeutic antibodies using its proprietary somatic hypermutation (SHM) technology
Founded
2005
Raised
$110M
Follow us
Alexa global traffic share
Twitter followers
Latest funding Show all
$75,000,000
IPO - 2017
Team Size
10+
Employees
$75,000,000 IPO
Xconomy

AnaptysBio Adds More Shares, Raises $75M in Stock Market Debut

Health Stock markets
Xconomy

Antibody Maker AnaptysBio Joins IPO Queue With $86M In Its Sights

Funding Health